Sg3 Management, LLC Uni Qure N.V. Call Options Transaction History

Sg3 Management, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $72,480 - $109,280	4,000 New	4,000 $90,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $657,500 - $1.02 Million	-50,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $1.89 Million - $2.8 Million	-130,000 Reduced 72.22%	50,000 $904,000
Q4 2021 Feb 15, 2022	BUY	$20.24 - $36.01 $202,399 - $360,100	10,000 Added 5.88%	180,000 $3.73 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $1.04 Million - $1.53 Million	40,000 Added 30.77%	170,000 $5.44 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $299,700 - $371,700	-10,000 Reduced 7.14%	130,000 $4 Million
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $2.49 Million - $3.57 Million	85,000 Added 154.55%	140,000 $4.72 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $3.89 Million - $5.57 Million	-110,000 Reduced 66.67%	55,000 $1.99 Million
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $1.39 Million - $1.83 Million	38,500 Added 30.43%	165,000 $6.08 Million
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $5.7 Million - $8.57 Million	126,500 New	126,500 $5.7 Million
Q1 2020 May 12, 2020	SELL	$40.01 - $73.97 $600,150 - $1.11 Million	-15,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$39.36 - $76.8 $196,800 - $384,000	-5,000 Reduced 25.0%	15,000 $590,000
Q2 2019 Aug 09, 2019	BUY	$52.76 - $82.19 $1.06 Million - $1.64 Million	20,000 New	20,000 $1.56 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.